ALLO

NASDAQStock

Allogene Therapeutics, Inc.

$2.46-0.17 (-6.27%)

52-Week Range

$0.95

$2.78

Key Stats

Market Cap

554.0M

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.50

Volume

2.7M

Avg Volume

4.8M

Performance

+46.15%

+63.58%

+114.78%

YTD

+82.96%

+19.90%

-56.05%

-93.67%

Price Chart

ETF Exposure

ALLO is held by 44 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
CNCR	Loncar Cancer Immunotherapy ETF	3.29%	60,621	$883K	$12.7M	0.79%
MOON	Direxion Moonshot Innovators ETF	2.37%	153,311	$468K	$19.5M	0.65%
BBC	Virtus Biotech Clinical Trials ETF	1.33%	191,227	$518K	$39.0M	0.65%
WDNA	WisdomTree BioRevolution Fund	1.32%	11,307	$31K	$2.3M	0.45%
NIFE	Direxion Fallen Knives ETF	0.99%	2,115	$23K	$2.3M	0.50%
QQQS	Invesco NASDAQ Future Gen 200 ETF	0.90%	45,405	$123K	$13.8M	0.20%
BTAL	AGF U.S. Market Neutral Anti-Beta Fund	0.27%	16,936	$405K	$364.1M	1.43%
MEDX	Horizon Kinetics Medical ETF	0.26%	18,388	$50K	$19.6M	0.85%
PQSG	PGIM ETF Trust - PGIM QMA Strategic Alpha Small-Cap Growth ETF	0.13%	777	$17K	$13.0M	N/A
PRFZ	Invesco RAFI US 1500 Small-Mid ETF	0.05%	467,649	$1.3M	$2.67B	0.34%
IBBQ	Invesco Nasdaq Biotechnology ETF	0.05%	12,556	$34K	$74.5M	0.19%
IBB	iShares Biotechnology ETF	0.04%	1,161,055	$3.1M	$8.50B	0.44%
BIB	ProShares - Ultra Nasdaq Biotechnology	0.03%	10,089	$27K	$86.8M	1.19%
IWN	iShares Russell 2000 Value ETF	0.03%	1,348,351	$3.7M	$12.45B	0.24%
VTWV	Vanguard Russell 2000 Value ETF	0.02%	106,723	$196K	$1.00B	0.06%
IWM	iShares Russell 2000 ETF	0.01%	3,716,632	$10.1M	$70.17B	0.19%
RESM	Columbia Research Enhanced Small Cap ETF	0.01%	154	$417	$3.1M	0.32%
SCHA	Schwab U.S. Small-Cap ETF	0.01%	787,786	$2.1M	$20.05B	0.04%
RSSL	Global X - Russell 2000 ETF	0.01%	70,227	$146K	$1.38B	0.08%
UWM	ProShares - Ultra Russell2000	0.01%	9,267	$25K	$264.2M	1.07%
VTWO	Vanguard Russell 2000 ETF	0.01%	732,202	$1.3M	$14.50B	0.06%
URTY	ProShares - UltraPro Russell2000	0.01%	9,205	$25K	$309.0M	1.08%
DFAS	Dimensional - US Small Cap ETF	0.01%	150,129	$407K	$12.82B	0.26%
VHT	Vanguard Health Care ETF	0.00%	454,877	$837K	$19.80B	0.09%
VXF	Vanguard Extended Market ETF	0.00%	1,799,598	$3.3M	$84.10B	0.05%
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	30,483	$83K	$2.37B	0.25%
SMMD	iShares Russell 2500 ETF	0.00%	55,551	$151K	$2.33B	0.23%
DFAC	Dimensional - US Core Equity 2 ETF	0.00%	241,276	$654K	$41.36B	0.17%
HDG	ProShares - Hedge Replication ETF	0.00%	171	$463	$23.2M	0.95%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	341,122	$924K	$81.53B	0.03%
SCHB	Schwab U.S. Broad Market ETF	0.00%	132,137	$358K	$38.14B	0.03%
CHEP	AGFiQ U.S. Market Neutral Value Fund	0.00%	-69	$0	$747K	1.42%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	13	$35	$61.4M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	43	$116	$81.5M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	73	$198	$81.7M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	84	$228	$64.1M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	100	$270	$59.0M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	83	$225	$42.9M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	55	$148	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	42	$112	$21.4M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	18	$50	$9.5M	0.12%
IWV	iShares Russell 3000 ETF	0.00%	25,010	$68K	$17.58B	0.20%
VTHR	Vanguard Russell 3000 ETF	0.00%	9,870	$18K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	4,879,191	$9.0M	$2.10T	0.03%

About ALLO ETF Exposure

Allogene Therapeutics, Inc. (ALLO) is held by 44 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 554.0M, ALLO is a widely held institutional stock. The stock currently trades at $2.46. Investors can gain exposure to ALLO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALLO, sorted by portfolio weight.